$20.21
0[0.00%]
At close: Apr 25
$20.21
0[0.00%]
PreMarket: 4:00PM EDT
Fresenius Medical Care
(NYSE:FMS)Fresenius Medical Care Stock (NYSE:FMS), Analyst Ratings, Price Targets, Predictions
Fresenius Medical Care AG has a consensus price target of $16.2, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from HSBC, Truist Securities, and Truist Securities on November 24, 2023, October 11, 2023, and July 13, 2023. With an average price target of $17.33 between HSBC, Truist Securities, and Truist Securities, there's an implied -14.23% downside for Fresenius Medical Care AG from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HSBC
Truist Securities
Truist Securities
RBC Capital
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Fresenius Medical Care
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/24/2023 | FMS | Buy Now | Fresenius Medical Care | $20.21 | — | HSBC | Sezgi Oezener | — | Upgrade | Reduce → Hold | Get Alert |
| 10/11/2023 | FMS | Buy Now | Fresenius Medical Care | $20.21 | 18.75% | Truist Securities | David Macdonald | $28 → $24 | Maintains | Hold | Get Alert |
| 07/13/2023 | FMS | Buy Now | Fresenius Medical Care | $20.21 | 38.55% | Truist Securities | David Macdonald | $26 → $28 | Maintains | Hold | Get Alert |
| 05/10/2023 | FMS | Buy Now | Fresenius Medical Care | $20.21 | 28.65% | Truist Securities | David Macdonald | $24 → $26 | Maintains | Hold | Get Alert |
| 04/13/2023 | FMS | Buy Now | Fresenius Medical Care | $20.21 | 18.75% | Truist Securities | David Macdonald | $22 → $24 | Maintains | Hold | Get Alert |
| 02/23/2023 | FMS | Buy Now | Fresenius Medical Care | $20.21 | 8.86% | Truist Securities | — | $17 → $22 | Maintains | Hold | Get Alert |
| 06/22/2022 | FMS | Buy Now | Fresenius Medical Care | $20.21 | 33.6% | Truist Securities | David Macdonald | $34 → $27 | Maintains | Hold | Get Alert |
| 11/23/2021 | FMS | Buy Now | Fresenius Medical Care | $20.21 | — | HSBC | Sezgi Oezener | — | Initiates | → Hold | Get Alert |
| 11/17/2021 | FMS | Buy Now | Fresenius Medical Care | $20.21 | 73.18% | RBC Capital | Frank Morgan | — | Maintains | Sector Perform | Get Alert |
| 11/11/2021 | FMS | Buy Now | Fresenius Medical Care | $20.21 | — | Jefferies | James VaneTempest | — | Upgrade | Underperform → Hold | Get Alert |
FAQ
What is the target price for Fresenius Medical Care (FMS)?
The latest price target for Fresenius Medical Care (NYSE: FMS) was reported by HSBC on November 24, 2023. The analyst firm set a price target for $0.00 expecting FMS to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fresenius Medical Care (FMS)?
The latest analyst rating for Fresenius Medical Care (NYSE: FMS) was provided by HSBC, and Fresenius Medical Care upgraded their hold rating.
When was the last upgrade for Fresenius Medical Care (FMS)?
The last upgrade for Fresenius Medical Care AG happened on November 24, 2023 when HSBC raised their price target to N/A. HSBC previously had a reduce for Fresenius Medical Care AG.
When was the last downgrade for Fresenius Medical Care (FMS)?
There is no last downgrade for Fresenius Medical Care.
When is the next analyst rating going to be posted or updated for Fresenius Medical Care (FMS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fresenius Medical Care, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fresenius Medical Care was filed on November 24, 2023 so you should expect the next rating to be made available sometime around November 24, 2024.
Is the Analyst Rating Fresenius Medical Care (FMS) correct?
While ratings are subjective and will change, the latest Fresenius Medical Care (FMS) rating was a upgraded with a price target of $0.00 to $0.00. The current price Fresenius Medical Care (FMS) is trading at is $20.21, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.